EC Healthcare

HKEX:2138.HK

0.57 (HKD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q2
Revenue 2,062.8972,089.7222,121.3121,982.1911,893.1861,475.821,443.681,283.037797.367830.0241,118.477979.403873.049704.823617.318565.896409.007371.131336.789331.504289.848
Cost of Revenue 1,384.4871,423.4911,761.9881,678.9241,521.7871,179.171987.28978.171596.052616.392682.174507.402373.554323.05292.011280.433205.394176.084139.739126.893133.728
Gross Profit 678.41666.231359.324303.267371.399296.649456.4304.866201.315213.632436.302472.001499.495381.773325.307285.463203.613195.047197.051204.612156.12
Gross Profit Ratio 0.3290.3190.1690.1530.1960.2010.3160.2380.2520.2570.390.4820.5720.5420.5270.5040.4980.5260.5850.6170.539
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 126.716111.05107.621232.371102.579161.428152.52115.99898.81591.25695.156120.561101.7494.06679.52663.85554.68743.30241.8595.58420.653
Selling & Marketing Expenses 92.56599.723107.49976.04796.66866.07373.3158.98650.39522.15102.29471.15483.38564.91362.0235.90232.55921.06316.95615.0328.897
SG&A 305.037298.955299.023273.357275.302198.172225.83172.837149.21113.405197.449191.715185.125158.979141.54699.75787.24664.36558.81561.25750.202
Other Expenses 0000000003.62100000000000
Operating Expenses 305.037298.955299.023273.357275.302198.172225.83172.837149.21109.784197.449270.988264.715210.309178.875130.681118.299115.41293.76486.25666.131
Operating Income 373.373367.27660.30129.9196.09798.477230.57132.02852.105103.848238.853198.278241.105166.817135.773145.82385.064113.946104.371122.99489.054
Operating Income Ratio 0.1810.1760.0280.0150.0510.0670.160.1030.0650.1250.2140.2020.2760.2370.220.2580.2080.3070.310.3710.307
Total Other Income Expenses Net -316.731-386.849-29.28-22.46128.297-6.715-0.25368.505-166.232-149.83710.061-72.97916.699-43.168-33.234-28.652-28.814-50.623-33.887-3.8592.408
Income Before Tax 56.642-19.57331.0217.449116.41291.763230.316200.53460.376112.489247.913209.179240.902179.626150.527157.05487.55480.059104.348119.13491.463
Income Before Tax Ratio 0.027-0.0090.0150.0040.0610.0620.160.1560.0760.1360.2220.2140.2760.2550.2440.2780.2140.2160.310.3590.316
Income Tax Expense 16.341-12.67213.8519.97519.18715.25535.65332.7357.56812.41137.84127.70237.87327.83124.18726.49714.61514.64720.45219.2116.609
Net Income 14.097-25.5986.651-10.39280.04637.293160.208148.93743.92889.066197.511166.866194.24153.716125.508127.17873.52565.19383.47199.93274.483
Net Income Ratio 0.007-0.0120.003-0.0050.0420.0250.1110.1160.0550.1070.1770.170.2220.2180.2030.2250.180.1760.2480.3010.257
EPS 0.012-0.0220.006-0.0090.0680.0320.140.140.0440.090.20.170.20.160.130.130.0750.0850.110.140.1
EPS Diluted 0.012-0.0220.006-0.0090.0680.0280.140.140.0440.090.20.170.20.160.130.130.0750.0850.110.140.1
EBITDA 233.885194.949375.228330.584435.118368.402436.848399.297195.124243.497380.752227.801273.327188.83151.385162.00198.06127.764115.194132.89697.305
EBITDA Ratio 0.1130.0930.1770.1670.230.250.3030.3110.2450.2930.340.2330.3130.2680.2450.2860.240.3440.3420.4010.336